If there are no long-term side effects to taking GLP1 agonists (remains to be seen), then I think the following will happen: - In the short term, the fitness i

If there are no long-term side effects to taking GLP1 agonists (remains to be seen), then I think the following will happen: - In the short term, the fitness industry (a multi-billion dollar market) and its dependents will crater, - Smaller, European-like, serving sizes will become the norm, and - You'll see more and much larger investments in de-alcoholifying beers, wines and spirits. I do not think this class of drugs will accelerate the adoption of universal healthcare in the US. For one, the healthcare industry employs a ton of people in towns like Bowling Green. (HCA, the biggest healthcare network in the US, is headquarted in Nashville, TN. Nashville is definitely bigger than Bowling Green, but people that lie in Murfreesboro and other small towns around Nashville work at HCA. Also, many insurance companies are headquartered in the Midwest, where jobs are relatively scant compared to the big coastal cities.) Any policy that ends with "and tens of thousands of jobs will be lost" is political suicide. Also, the modern healthcare industry in the US was built and designed around private, employer-provided health insurance. Reverse-engineering decades-old business logic and institutional process to fit a government-provided system would be a gigantic and extremely expensive underatking that we would pay for (through taxes).